Trichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent manner

被引:33
作者
You, Bo Ra [1 ]
Park, Woo Hyun [1 ]
机构
[1] Chonbuk Natl Univ, Res Inst Endocrine Sci, Sch Med, Dept Physiol, JeonJu 561180, South Korea
基金
新加坡国家研究基金会;
关键词
trichostatin A; histone deacetylase; apoptosis; HeLa; reactive oxygen species; HISTONE DEACETYLASE INHIBITOR; MANGANESE SUPEROXIDE-DISMUTASE; HDAC INHIBITORS; CANCER CELLS; EXPRESSION; DIFFERENTIATION; THIOREDOXIN; EPIGENETICS; ARREST;
D O I
10.3892/ijo.2012.1705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Trichostatin A (TSA) as a HDAC inhibitor can regulate many biological properties including apoptosis and cell proliferation in various cancer cells. Here, we evaluated the effect of TSA on the growth and death of He La cervical cancer cells in relation to reactive oxygen species (ROS) and glutathione (GSH) levels. Dose- and time-dependent growth inhibition was observed in He La cells with an IC50, of approximately 20 nM at 72 h. This agent also induced apoptotic cell death, as evidenced by annexin V-FITC staining cells, caspase-3 activation and the loss of mitochondrial membrane potential (MMP; Delta Psi(m)). In addition, the administration of Bcl-2 siRNA intensified TSA-induced He La cell death. All of the tested caspase inhibitors significantly rescued some cells from TSA-induced He La cell death. TSA increased O-2(center dot-) level and induced GSH depletion in He La cells. Caspase inhibitors significantly attenuated O-2(center dot-) level and GSH depletion in TSA-treated He La cells. In addition, N-acetyl cysteine (NAC; a well known antioxidant) significantly prevented cell death and GSH depletion in TSA-treated He La cells via decreasing O-2(center dot-) level. In conclusion, TSA inhibited the growth of HeLa cells via Bcl-2-mediated apoptosis, which was closely related to O-2(center dot-) and GSH content levels.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 29 条
[1]  
Anton M, 2004, Ceska Gynekol, V69, P3
[2]   Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: The role of glutathione [J].
Brechbuhl, Heather M. ;
Kachadourian, Remy ;
Min, Elysia ;
Chan, Daniel ;
Day, Brian J. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 258 (01) :1-9
[3]   EPIGENETICS Histone modification at the gene level [J].
Burgess, Darren J. .
NATURE REVIEWS CANCER, 2012, 12 (03) :156-156
[4]   ROMIDEPSIN FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA [J].
Campas-Moya, Clara .
DRUGS OF TODAY, 2009, 45 (11) :787-795
[5]   Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas [J].
Duan, H ;
Heckman, CA ;
Boxer, LM .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (05) :1608-1619
[6]   Epigenetics of cervical cancer. An overview and therapeutic perspectives [J].
Duenas-Gonzalez, Alfonso ;
Lizano, Marcela ;
Candelaria, Myrna ;
Cetina, Lucely ;
Arce, Claudia ;
Cervera, Eduardo .
MOLECULAR CANCER, 2005, 4 (1)
[7]   Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies [J].
Ellis, Leigh ;
Pili, Roberto .
PHARMACEUTICALS, 2010, 3 (08) :2441-2469
[8]   Histone deacetylase inhibitors and genomic instability [J].
Eot-Houllier, Gregory ;
Fulcrand, Geraldine ;
Magnaghi-Jaulin, Laura ;
Jaulin, Christian .
CANCER LETTERS, 2009, 274 (02) :169-176
[9]   Enhancement of Carboplatin-Mediated Lung Cancer Cell Killing by Simultaneous Disruption of Glutathione and Thioredoxin Metabolism [J].
Fath, Melissa A. ;
Ahmad, Iman M. ;
Smith, Carmen J. ;
Spence, Jacquelyn ;
Spitz, Douglas R. .
CLINICAL CANCER RESEARCH, 2011, 17 (19) :6206-6217
[10]   Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery [J].
Ganesan, A. ;
Nolan, L. ;
Crabb, S. J. ;
Packham, G. .
CURRENT CANCER DRUG TARGETS, 2009, 9 (08) :963-981